Clinical Trial Update: Sofosbuvir/Velpatasvir in Adults With Chronic Hepatitis C Virus Infection Who Are on Dialysis for End Stage Renal Disease [Phase 2]

View source ↗

Summary

Phase 2 trial assessing sofosbuvir/velpatasvir in adults with chronic hepatitis C on dialysis for end-stage renal disease has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Sofosbuvir/Velpatasvir (sofosbuvir/velpatasvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Chronic Hepatitis C | Phase 2 | Status: COMPLETED | Results posted: 2019-11-12